Return to homepagePandemic Pact

Development of a therapeutic anti-dengue polymeric IgG antibody

Grant number: RF-TAA-2021-T03

Grant search

Key facts

  • Disease

    Dengue

  • Start & end year

    2021
    2023

  • Known Financial Commitments (USD)

    $190,177.3

  • Funder

    RIGHT Foundation

  • Principal Investigator

    Rajko Reljic

  • Research Location

    41, Belize

  • Lead Research Institution

    St George's University of London (SGUL)

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Development of a polymeric anti-dengue IgG construct with LALA mutation to eliminate the risk of antibody dependent enhancement (ADE).